MARKET

VKTX

VKTX

Viking Therapeutics Inc
NASDAQ
27.56
+0.55
+2.04%
Pre Market: 27.60 +0.04 +0.15% 08:47 05/08 EDT
OPEN
27.16
PREV CLOSE
27.01
HIGH
27.66
LOW
26.90
VOLUME
21.29K
TURNOVER
--
52 WEEK HIGH
81.86
52 WEEK LOW
18.92
MARKET CAP
3.10B
P/E (TTM)
-23.9298
1D
5D
1M
3M
1Y
5Y
1D
Viking Therapeutics put volume heavy and directionally bearish
TipRanks · 2d ago
Weekly Report: what happened at VKTX last week (0428-0502)?
Weekly Report · 3d ago
Eli Lilly's Meltdown Triggers Near Doubling Upside Potential - Reiterate Buy
Seeking Alpha · 4d ago
ARMOUR, BioCryst, Viking, Builders, Hims: Trending by Analysts
TipRanks · 5d ago
Notable Friday Option Activity: VKTX, FUBO, PYPL
NASDAQ · 5d ago
Viking Therapeutics call volume above normal and directionally bullish
TipRanks · 5d ago
3 Market Predictions For May
Seeking Alpha · 6d ago
Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain
NASDAQ · 04/30 07:15
More
About VKTX
More
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for the treatment of metabolic and endocrine disorders. Its clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptors for the potential treatment of various metabolic disorders. It is evaluating an oral formulation of VK2735 in a Phase II trial. It is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. Its newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists for the treatment of obesity and other metabolic disorders. In the rare disease space, it is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy.
Recently
Symbol
Price
%Change

Webull offers Viking Therapeutics Inc stock information, including NASDAQ: VKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTX stock methods without spending real money on the virtual paper trading platform.